Prokidney Corp Stock Probability of Future Stock Price Finishing Over 1.69
| PROK Stock | USD 1.69 0.05 2.87% |
ProKidney |
ProKidney Corp Target Price Odds to finish over 1.69
The tendency of ProKidney Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.69 | 90 days | 1.69 | about 84.13 |
Based on a normal probability distribution, the odds of ProKidney Corp to move above the current price in 90 days from now is about 84.13 (This ProKidney Corp probability density function shows the probability of ProKidney Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.84 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ProKidney Corp will likely underperform. Additionally ProKidney Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ProKidney Corp Price Density |
| Price |
Predictive Modules for ProKidney Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProKidney Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ProKidney Corp Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ProKidney Corp is not an exception. The market had few large corrections towards the ProKidney Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProKidney Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProKidney Corp within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.67 | |
β | Beta against Dow Jones | 3.84 | |
σ | Overall volatility | 0.30 | |
Ir | Information ratio | -0.05 |
ProKidney Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProKidney Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProKidney Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ProKidney Corp generated a negative expected return over the last 90 days | |
| ProKidney Corp has high historical volatility and very poor performance | |
| ProKidney Corp may become a speculative penny stock | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (135.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License ... |
ProKidney Corp Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ProKidney Stock often depends not only on the future outlook of the current and potential ProKidney Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProKidney Corp's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 61.7 M | |
| Cash And Short Term Investments | 362.9 M |
ProKidney Corp Technical Analysis
ProKidney Corp's future price can be derived by breaking down and analyzing its technical indicators over time. ProKidney Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ProKidney Corp. In general, you should focus on analyzing ProKidney Stock price patterns and their correlations with different microeconomic environments and drivers.
ProKidney Corp Predictive Forecast Models
ProKidney Corp's time-series forecasting models is one of many ProKidney Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ProKidney Corp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ProKidney Corp
Checking the ongoing alerts about ProKidney Corp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ProKidney Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ProKidney Corp generated a negative expected return over the last 90 days | |
| ProKidney Corp has high historical volatility and very poor performance | |
| ProKidney Corp may become a speculative penny stock | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (135.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License ... |
Check out ProKidney Corp Backtesting, ProKidney Corp Valuation, ProKidney Corp Correlation, ProKidney Corp Hype Analysis, ProKidney Corp Volatility, ProKidney Corp History as well as ProKidney Corp Performance. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Return On Assets (0.20) | Return On Equity (0.31) |
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.